Re: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
- PMID: 10218517
- DOI: 10.1093/jnci/91.8.728
Re: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
Comment on
-
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.J Natl Cancer Inst. 1998 Sep 16;90(18):1346-60. doi: 10.1093/jnci/90.18.1346. J Natl Cancer Inst. 1998. PMID: 9747866 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
